97 related articles for article (PubMed ID: 25852009)
1. Prognostic significance of autocrine motility factor receptor expression by colorectal cancer and lymph node metastases.
Halwani Y; Kojic LD; Chan SK; Phang TP; Masoudi H; Jones SJ; Nabi IR; Wiseman SM
Am J Surg; 2015 May; 209(5):884-9; discussion 889. PubMed ID: 25852009
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of cell motility activation factors in patients with tongue squamous cell carcinoma.
Endo K; Shirai A; Furukawa M; Yoshizaki T
Hum Pathol; 2006 Aug; 37(8):1111-6. PubMed ID: 16867875
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of the autocrine motility factor receptor correlates with poor prognosis and promotes metastasis in gastric carcinoma.
Huang Z; Zhang N; Zha L; Mao HC; Chen X; Xiang JF; Zhang H; Wang ZW
Asian Pac J Cancer Prev; 2014; 15(2):989-97. PubMed ID: 24568530
[TBL] [Abstract][Full Text] [Related]
4. Correlation between loss of E-cadherin expression and overexpression of autocrine motility factor receptor in association with progression of human gastric cancers.
Kawanishi K; Doki Y; Shiozaki H; Yano M; Inoue M; Fukuchi N; Utsunomiya T; Watanabe H; Monden M
Am J Clin Pathol; 2000 Feb; 113(2):266-74. PubMed ID: 10664629
[TBL] [Abstract][Full Text] [Related]
5. HER3 expression in patients with primary colorectal cancer and corresponding lymph node metastases related to clinical outcome.
Lédel F; Hallström M; Ragnhammar P; Öhrling K; Edler D
Eur J Cancer; 2014 Feb; 50(3):656-62. PubMed ID: 24300455
[TBL] [Abstract][Full Text] [Related]
6. Elevated expression of autocrine motility factor receptor correlates with overexpression of RhoC and indicates poor prognosis in hepatocellular carcinoma.
Wang W; Yang LY; Yang ZL; Peng JX; Yang JQ
Dig Dis Sci; 2007 Mar; 52(3):770-5. PubMed ID: 17265125
[TBL] [Abstract][Full Text] [Related]
7. Autocrine motility factor receptor: a clinical review.
Chiu CG; St-Pierre P; Nabi IR; Wiseman SM
Expert Rev Anticancer Ther; 2008 Feb; 8(2):207-17. PubMed ID: 18279062
[TBL] [Abstract][Full Text] [Related]
8. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological characteristics of skipping lymph node metastases in patients with colorectal cancer.
Yamamoto Y; Takahashi K; Yasuno M; Sakoma T; Mori T
Jpn J Clin Oncol; 1998 Jun; 28(6):378-82. PubMed ID: 9730153
[TBL] [Abstract][Full Text] [Related]
10. Detection of thymidylate synthase expression in lymph node metastases of colorectal cancer can improve the prognostic information.
Ohrling K; Edler D; Hallström M; Ragnhammar P; Blomgren H
J Clin Oncol; 2005 Aug; 23(24):5628-34. PubMed ID: 16009948
[TBL] [Abstract][Full Text] [Related]
11. The autocrine motility factor receptor is overexpressed on the surface of B cells in Binet C chronic lymphocytic leukemia.
Grund S; Olsson B; Jernås M; Jacobsson S; Swolin B; Nabi IR; Carlsson L; Wadenvik H
Med Oncol; 2011 Dec; 28(4):1542-8. PubMed ID: 20574759
[TBL] [Abstract][Full Text] [Related]
12. Expression of autocrine motility factor receptor in cutaneous malignant melanoma.
Nagai Y; Ishikawa O; Miyachi Y; Watanabe H
Dermatology; 1996; 192(1):8-11. PubMed ID: 8832943
[TBL] [Abstract][Full Text] [Related]
13. Autocrine motility factor receptor expression implies an unfavourable prognosis in resected stage I pulmonary adenocarcinomas.
Kaynak K; Kara M; Oz B; Akgoz B; Sar M; Raz A
Acta Chir Belg; 2005 Aug; 105(4):378-82. PubMed ID: 16184720
[TBL] [Abstract][Full Text] [Related]
14. Autocrine motility factor receptor expression in patients with stage I non-small cell lung cancer.
Kara M; Ohta Y; Tanaka Y; Oda M; Watanabe Y
Ann Thorac Surg; 2001 Mar; 71(3):944-8. PubMed ID: 11269478
[TBL] [Abstract][Full Text] [Related]
15. Expression of autocrine motility factor (AMF) and its receptor, AMFR, in human breast cancer.
Jiang WG; Raz A; Douglas-Jones A; Mansel RE
J Histochem Cytochem; 2006 Feb; 54(2):231-41. PubMed ID: 16204225
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of apical lymph node metastasis in patients with node-positive rectal cancer.
Peng J; Wu H; Li X; Sheng W; Huang D; Guan Z; Wang M; Cai S
Colorectal Dis; 2013 Jan; 15(1):e13-20. PubMed ID: 23057847
[TBL] [Abstract][Full Text] [Related]
17. UCHL5 expression associates with improved survival in lymph-node-positive rectal cancer.
Arpalahti L; Hagström J; Mustonen H; Lundin M; Haglund C; Holmberg CI
Tumour Biol; 2017 Jul; 39(7):1010428317716078. PubMed ID: 28681694
[TBL] [Abstract][Full Text] [Related]
18. Distribution of lymph node metastases is an independent predictor of survival for sigmoid colon and rectal cancer.
Huh JW; Kim YJ; Kim HR
Ann Surg; 2012 Jan; 255(1):70-8. PubMed ID: 22133895
[TBL] [Abstract][Full Text] [Related]
19. A novel data-driven prognostic model for staging of colorectal cancer.
Manilich EA; Kiran RP; Radivoyevitch T; Lavery I; Fazio VW; Remzi FH
J Am Coll Surg; 2011 Nov; 213(5):579-588, 588.e1-2. PubMed ID: 21925905
[TBL] [Abstract][Full Text] [Related]
20. UQCRC1 downregulation is correlated with lymph node metastasis and poor prognosis in CRC.
Li W; Wubulikasimu G; Zhao X; Wang C; Liu R; Wang L; Zhu X; Chen Z
Eur J Surg Oncol; 2019 Jun; 45(6):1005-1010. PubMed ID: 30842031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]